+191.8%
MRNA vs XRT
+49.7%
+142.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | XRT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.4% | -3.9% | -4.0% |
| 7D | -12.1% | +1.7% | -13.9% | -13.8% |
| 30D | -1.3% | +7.5% | -8.8% | -10.0% |
| 3M | +250.9% | +2.2% | +248.7% | +246.3% |
| 6M | +343.0% | +14.7% | +328.4% | +287.2% |
| YTD | +657.4% | +7.5% | +649.9% | +606.8% |
| 1Y | +794.9% | +14.1% | +780.8% | +688.8% |
| All | +191.8% | +49.7% | +142.1% | +95.8% |
Cumulative growth
Daily Returns
Daily percentage return beside XRT.
Daily Out/Under-Performance
Portfolio return minus XRT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XRT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded XRT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling